These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26043691)

  • 1. Src tyrosyl phosphorylates cortactin in response to prolactin.
    Hammer A; Laghate S; Diakonova M
    Biochem Biophys Res Commun; 2015 Aug; 463(4):644-9. PubMed ID: 26043691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin-induced PAK1 tyrosyl phosphorylation promotes FAK dephosphorylation, breast cancer cell motility, invasion and metastasis.
    Hammer A; Diakonova M
    BMC Cell Biol; 2016 Aug; 17(1):31. PubMed ID: 27542844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosyl phosphorylated serine-threonine kinase PAK1 is a novel regulator of prolactin-dependent breast cancer cell motility and invasion.
    Hammer A; Diakonova M
    Adv Exp Med Biol; 2015; 846():97-137. PubMed ID: 25472536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of tyrosine 285 of PAK1 facilitates βPIX/GIT1 binding and adhesion turnover.
    Hammer A; Oladimeji P; De Las Casas LE; Diakonova M
    FASEB J; 2015 Mar; 29(3):943-59. PubMed ID: 25466889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of c-Src by prolactin is independent of Jak2.
    Fresno Vara JA; Carretero MV; Gerónimo H; Ballmer-Hofer K; Martín-Pérez J
    Biochem J; 2000 Jan; 345 Pt 1(Pt 1):17-24. PubMed ID: 10600634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAK1 regulates breast cancer cell invasion through secretion of matrix metalloproteinases in response to prolactin and three-dimensional collagen IV.
    Rider L; Oladimeji P; Diakonova M
    Mol Endocrinol; 2013 Jul; 27(7):1048-64. PubMed ID: 23744893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways.
    Acosta JJ; Muñoz RM; González L; Subtil-Rodríguez A; Dominguez-Caceres MA; García-Martínez JM; Calcabrini A; Lazaro-Trueba I; Martín-Pérez J
    Mol Endocrinol; 2003 Nov; 17(11):2268-82. PubMed ID: 12907754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosyl phosphorylated PAK1 regulates breast cancer cell motility in response to prolactin through filamin A.
    Hammer A; Rider L; Oladimeji P; Cook L; Li Q; Mattingly RR; Diakonova M
    Mol Endocrinol; 2013 Mar; 27(3):455-65. PubMed ID: 23340249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An EGFR-Src-Arg-cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion.
    Mader CC; Oser M; Magalhaes MA; Bravo-Cordero JJ; Condeelis J; Koleske AJ; Gil-Henn H
    Cancer Res; 2011 Mar; 71(5):1730-41. PubMed ID: 21257711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the Src-cortactin pathway in migration induced by IGF-1 and EGF in human breast cancer cells.
    Mezi S; Todi L; Orsi E; Angeloni A; Mancini P
    Int J Oncol; 2012 Dec; 41(6):2128-38. PubMed ID: 23023326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adapter protein SH2B1beta binds filamin A to regulate prolactin-dependent cytoskeletal reorganization and cell motility.
    Rider L; Diakonova M
    Mol Endocrinol; 2011 Jul; 25(7):1231-43. PubMed ID: 21566085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
    Neilson LM; Zhu J; Xie J; Malabarba MG; Sakamoto K; Wagner KU; Kirken RA; Rui H
    Mol Endocrinol; 2007 Sep; 21(9):2218-32. PubMed ID: 17550976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF-1 receptor transactivation mediates Src-dependent cortactin phosphorylation in response to angiotensin II.
    Zahradka P; Storie B; Wright B
    Can J Physiol Pharmacol; 2009 Oct; 87(10):805-12. PubMed ID: 19898563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAK1 translocates into nucleus in response to prolactin but not to estrogen.
    Oladimeji P; Diakonova M
    Biochem Biophys Res Commun; 2016 Apr; 473(1):206-211. PubMed ID: 27003261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase.
    Frasor J; Barkai U; Zhong L; Fazleabas AT; Gibori G
    Mol Endocrinol; 2001 Nov; 15(11):1941-52. PubMed ID: 11682625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptosporidium parvum invasion of biliary epithelia requires host cell tyrosine phosphorylation of cortactin via c-Src.
    Chen XM; Huang BQ; Splinter PL; Cao H; Zhu G; McNiven MA; LaRusso NF
    Gastroenterology; 2003 Jul; 125(1):216-28. PubMed ID: 12851885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A non-catalytic function of the Src family tyrosine kinases controls prolactin-induced Jak2 signaling.
    García-Martínez JM; Calcabrini A; González L; Martín-Forero E; Agulló-Ortuño MT; Simon V; Watkin H; Anderson SM; Roche S; Martín-Pérez J
    Cell Signal; 2010 Mar; 22(3):415-26. PubMed ID: 19892015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells.
    Nouhi Z; Chughtai N; Hartley S; Cocolakis E; Lebrun JJ; Ali S
    Cancer Res; 2006 Feb; 66(3):1824-32. PubMed ID: 16452244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive tyrosine phosphorylation of ErbB-2 via Jak2 by autocrine secretion of prolactin in human breast cancer.
    Yamauchi T; Yamauchi N; Ueki K; Sugiyama T; Waki H; Miki H; Tobe K; Matsuda S; Tsushima T; Yamamoto T; Fujita T; Taketani Y; Fukayama M; Kimura S; Yazaki Y; Nagai R; Kadowaki T
    J Biol Chem; 2000 Oct; 275(43):33937-44. PubMed ID: 10938266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.